vs

Side-by-side financial comparison of CIMPRESS plc (CMPR) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.4× CIMPRESS plc). ResMed runs the higher net margin — 27.6% vs 4.7%, a 22.9% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 11.0%).

Cimpress plc is an American Irish-domiciled multinational technology company that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods. Those products are sold to small businesses, graphic designers and consumers through a number of customer-facing brands that Cimpress operates.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

CMPR vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.4× larger
RMD
$1.4B
$1.0B
CMPR
Growing faster (revenue YoY)
RMD
RMD
+0.0% gap
RMD
11.0%
11.0%
CMPR
Higher net margin
RMD
RMD
22.9% more per $
RMD
27.6%
4.7%
CMPR

Income Statement — Q2 FY2026 vs Q4 FY2026

Metric
CMPR
CMPR
RMD
RMD
Revenue
$1.0B
$1.4B
Net Profit
$49.3M
$392.6M
Gross Margin
46.8%
61.8%
Operating Margin
8.5%
34.6%
Net Margin
4.7%
27.6%
Revenue YoY
11.0%
11.0%
Net Profit YoY
-19.2%
13.9%
EPS (diluted)
$1.95
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMPR
CMPR
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.0B
$1.4B
Q3 25
$863.3M
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.2B
Q2 24
$1.2B
Net Profit
CMPR
CMPR
RMD
RMD
Q2 26
$392.6M
Q4 25
$49.3M
$392.6M
Q3 25
$7.6M
$348.5M
Q2 25
$379.7M
Q1 25
$365.0M
Q4 24
$344.6M
Q3 24
$311.4M
Q2 24
$292.2M
Gross Margin
CMPR
CMPR
RMD
RMD
Q2 26
61.8%
Q4 25
46.8%
61.8%
Q3 25
46.7%
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Q2 24
58.5%
Operating Margin
CMPR
CMPR
RMD
RMD
Q2 26
34.6%
Q4 25
8.5%
34.6%
Q3 25
5.7%
33.4%
Q2 25
33.7%
Q1 25
33.0%
Q4 24
32.5%
Q3 24
31.6%
Q2 24
31.2%
Net Margin
CMPR
CMPR
RMD
RMD
Q2 26
27.6%
Q4 25
4.7%
27.6%
Q3 25
0.9%
26.1%
Q2 25
28.2%
Q1 25
28.3%
Q4 24
26.9%
Q3 24
25.4%
Q2 24
23.9%
EPS (diluted)
CMPR
CMPR
RMD
RMD
Q2 26
$2.68
Q4 25
$1.95
$2.68
Q3 25
$0.30
$2.37
Q2 25
$2.58
Q1 25
$2.48
Q4 24
$2.34
Q3 24
$2.11
Q2 24
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMPR
CMPR
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$258.0M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$-530.7M
$6.3B
Total Assets
$2.1B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMPR
CMPR
RMD
RMD
Q2 26
$1.4B
Q4 25
$258.0M
$1.4B
Q3 25
$200.5M
$1.4B
Q2 25
$1.2B
Q1 25
$932.7M
Q4 24
$521.9M
Q3 24
$426.4M
Q2 24
$238.4M
Total Debt
CMPR
CMPR
RMD
RMD
Q2 26
$663.8M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
CMPR
CMPR
RMD
RMD
Q2 26
$6.3B
Q4 25
$-530.7M
$6.3B
Q3 25
$-571.3M
$6.1B
Q2 25
$6.0B
Q1 25
$5.5B
Q4 24
$5.3B
Q3 24
$5.2B
Q2 24
$4.9B
Total Assets
CMPR
CMPR
RMD
RMD
Q2 26
$8.5B
Q4 25
$2.1B
$8.5B
Q3 25
$2.0B
$8.3B
Q2 25
$8.2B
Q1 25
$7.6B
Q4 24
$7.1B
Q3 24
$7.2B
Q2 24
$6.9B
Debt / Equity
CMPR
CMPR
RMD
RMD
Q2 26
0.11×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMPR
CMPR
RMD
RMD
Operating Cash FlowLast quarter
$164.7M
Free Cash FlowOCF − Capex
$139.5M
FCF MarginFCF / Revenue
13.4%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.34×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMPR
CMPR
RMD
RMD
Q2 26
Q4 25
$164.7M
$339.7M
Q3 25
$25.1M
$457.3M
Q2 25
$538.8M
Q1 25
$578.7M
Q4 24
$308.6M
Q3 24
$325.5M
Q2 24
$440.1M
Free Cash Flow
CMPR
CMPR
RMD
RMD
Q2 26
Q4 25
$139.5M
$311.2M
Q3 25
$-1.3M
$414.4M
Q2 25
$508.2M
Q1 25
$557.9M
Q4 24
$288.0M
Q3 24
$307.7M
Q2 24
$415.2M
FCF Margin
CMPR
CMPR
RMD
RMD
Q2 26
Q4 25
13.4%
21.9%
Q3 25
-0.1%
31.0%
Q2 25
37.7%
Q1 25
43.2%
Q4 24
22.5%
Q3 24
25.1%
Q2 24
33.9%
Capex Intensity
CMPR
CMPR
RMD
RMD
Q2 26
Q4 25
2.4%
2.0%
Q3 25
3.1%
3.2%
Q2 25
2.3%
Q1 25
1.6%
Q4 24
1.6%
Q3 24
1.5%
Q2 24
2.0%
Cash Conversion
CMPR
CMPR
RMD
RMD
Q2 26
Q4 25
3.34×
0.87×
Q3 25
3.28×
1.31×
Q2 25
1.42×
Q1 25
1.59×
Q4 24
0.90×
Q3 24
1.05×
Q2 24
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMPR
CMPR

Vista$532.8M51%
Print Brothers$219.9M21%
National Pen$150.9M14%
The Print Group$115.2M11%
All Other Businesses$67.2M6%

RMD
RMD

Segment breakdown not available.

Related Comparisons